Unimpaired postprandial pancreatic polypeptide secretion in Parkinson's disease and REM sleep behavior disorder

Movement Disorders

Volumn 28, Issue 4, 2013, Pages 529-533

  Unger, Marcus M ^a,b   Ekman, Rolf ^c   Björklund, Anna Karin ^c   Karlsson, Gösta ^c   Andersson, Chatarina ^c   Mankel, Katharina ^a,d   Bohne, Katharina ^e   Tebbe, Johannes J ^f   Stiasny Kolster, Karin ^a,g   Möller, Jens C ^a,h   Mayer, Geert ^a,i   Kann, Peter H ^a   Oertel, Wolfgang H ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Sankt Gertrauden Krankenhaus   (Germany)

^f KLINIKUM LIPPE DETMOLD   (Germany)

^g UNIVERSITY HOSPITAL MARBURG   (Germany)

^h Ospedale Regionale di Lugano   (Sweden)

ⁱ Hephata Clinic for Neurology   (Germany)

Author keywords

Motilin; Pancreatic polypeptide (PP); Parkinson's disease; REM sleep behavior disorder (RBD); Vagal nerve

Indexed keywords

MOTILIN; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN SECRETION; REM SLEEP; SLEEP BEHAVIOR DISORDER; SLEEP DISORDER; VAGUS NERVE;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTILIN; PANCREATIC POLYPEPTIDE; PARKINSON DISEASE; POSTPRANDIAL PERIOD; REM SLEEP BEHAVIOR DISORDER;

EID: 84876113457     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25246     Document Type: Article

References (34)

1. Rudnicki M, Rigel DF, McFadden DW. Vagal cooling blocks circulating neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) release. J Surg Res. 1991;51:40-45.
2. Niebel W, Eysselein VE, Singer MV. Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog. Dig Dis Sci. 1987;32:1004-1009.
3. Balaji NS, Crookes PF, Banki F, Hagen JA, Ardill JE, DeMeester TR. A safe and noninvasive test for vagal integrity revisited. Arch Surg. 2002;137:954-958; discussion 958-959.
4. Hossdorf T, Wagner M, Hoppe HW. Pancreatic polypeptide (PP) response to food in type I diabetics with and without diabetic autonomic neuropathy. Hepatogastroenterology. 1988;35:238-241.
5. Kohler H, Becker HD. Total denervation of the pancreas does not alter the pancreatic polypeptide response to food intake. Digestion. 1987;37:149-155.
6. Debas HT, Taylor IL, Seal AM, Passaro EP Jr. Evidence for vagus-dependent pancreatic polypeptide-releasing factor in the antrum: studies with the autotransplanted dog pancreas. Surgery. 1982;92:309-314.
7. Mochiki E, Inui A, Satoh M, Mizumoto A, Itoh Z. Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs. Am J Physiol 1997;272( 2 Pt 1):G224-232.
8. Masclee AA, Gielkens HG, Ledeboer ML, van der Kleij FG, Jebbink MC, Lamers CB. Effect of antrectomy and truncal vagotomy on erythromycin induced pancreatic polypeptide secretion. Regul Pept. 1995;58:157-161.
9. Pathak RD, Tran TH, Burshell AL. A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor. J Clin Endocrinol Metab. 2004;89:581-584.
10. Stern N, Sowers JR, Taylor IL, Golub M. Dopaminergic modulation of meal-stimulated and circadian secretion of pancreatic polypeptide in man. J Clin Endocrinol Metab. 1983;56:300-304.
11. Linnestad P, Guldvog I, Schrumpf E. Effects of dopamine and dopamine antagonists on postprandial release of pancreatic polypeptide in dogs and in healthy volunteers. Scand J Gastroenterol. 1983;18:81-85.
12. Sowers JR, Stern N, Taylor IL. Evidence for dopaminergic modulation of pancreatic polypeptide secretion in man. Life Sci. 1982;31:2971-2975.
13. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197-211.
14. Buob A, Winter H, Kindermann M, et al. Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson's disease. Clin Res Cardiol. 2010;99:701-706.
15. Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci. 2009;276:79-83.
16. Valappil RA, Black JE, Broderick MJ, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord. 2010;25:2296-2303.
17. Kaneoke Y, Koike Y, Sakurai N, et al. Gastrointestinal dysfunction in Parkinson's disease detected by electrogastroenterography. J Auton Nerv Syst. 1995;50:275-281.
18. Ferini-Strambi L, Franceschi M, Pinto P, Zucconi M, Smirne S. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology. 1992;38:92-98.
19. Witteman BJ, Hopman WP, Brans P, et al. Pancreatic polypetide response to insulin induced hypogylcaemia in Parkinson's disease. Eur J Gastroenterol Hepatol. 1999;11:A78.
20. Broussolle E, Borson F, Gonzalez de Suso JM, Chayvialle JA, Beylot M, Chazot G. [Increase of energy expenditure in Parkinson's disease]. Rev Neurol (Paris). 1991;147:46-51.
21. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745-752.
22. ASDA. The International Classification of Sleep Disorders, 2nd edition: Diagnostic and Coding Manual. Chicago, IL:American Sleep Disorders Association;2005.
23. Unger MM, Moller JC, Mankel K, et al. Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?J Neurol. 2011;258:982-990.
24. Sjolund K, Ekman R, Akre F, Lindner P. Motilin in chronic idiopathic constipation. Scand J Gastroenterol. 1986;21:914-918.
25. Asakawa A, Inui A, Yuzuriha H, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 2003;124:1325-1336.
26. Whitcomb DC, Taylor IL, Vigna SR. Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. Am J Physiol. 1990;259:G687-G691.
27. Whitcomb DC, Puccio AM, Vigna SR, Taylor IL, Hoffman GE. Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res. 1997;760:137-149.
28. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006;396:67-72.
29. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121-134.
30. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology. 2003;144:5184-5187.
31. Fiorucci S, Scionti L, Bosso R, et al. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci. 1992;37:1671-1677.
32. Kumar R, Salehi A, Rehfeld JF, Hoglund P, Lindstrom E, Hakanson R. Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets. Regul Pept. 2010;164:65-70.
33. Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab. 2003;88:701-704.
34. Qader SS, Hakanson R, Rehfeld JF, Lundquist I, Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept. 2008;146:230-237.